Aller au contenu
Sommeil et rythmesÉtude de cohorte3 min read

Poorer sleep quality and later sleep timing linked to low bone and muscle mass at midlife

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Poor sleep quality and later sleep timing are risk factors for osteopenia and sarcopenia in middle-aged men and women: The NEO study. · PloS one · 2017 · Article original ↗

À retenir

Among 915 adults aged 45-65, a higher (worse) Pittsburgh Sleep Quality Index score was associated with osteopenia (OR 1.09, 95% CI 1.03-1.14) and sarcopenia (OR 1.10, 1.02-1.19), and sleep timing one hour later with osteopenia (OR 1.51, 1.08-2.11). The analysis is cross-sectional with self-reported sleep, so it cannot show that poor sleep causes bone or muscle loss.

Study design

Étude de cohorte

Reading basis

Published abstract

Reading focus

Association & confounding

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Short or poor sleep has metabolic downsides, and osteopenia (low bone density) and sarcopenia (low muscle mass) often occur together and raise the risk of fractures and disease. Studies linking sleep to either are few and inconsistent. The authors tested whether sleep duration, quality and timing relate to osteopenia and sarcopenia, and whether sex and menopause change the picture.

Population et méthode

Cross-sectional analysis of 915 participants aged 45-65 years (56% women, median BMI 26 kg/m2, range 18-56) in the population-based Netherlands Epidemiology of Obesity (NEO) study. Sleep duration, quality and timing came from the Pittsburgh Sleep Quality Index (PSQI). Bone mineral density and relative appendicular muscle mass were measured by DXA scans. Linear and logistic regression related sleep to bone density, muscle mass, osteopenia (T-score between -1 and -2.5) and sarcopenia (muscle mass 1 SD below average), adjusting for confounders.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Osteopenia was more likely with each one-unit higher PSQI score (OR 1.09, 95% CI 1.03-1.14), worse self-rated sleep quality (1.76, 1.03-3.01), longer sleep latency (1.18, 1.06-1.31) and a one hour later sleep timing (1.51, 1.08-2.11).
  2. 2
    Sleep duration was not associated with osteopenia (OR 1.05, 0.90-1.23).
  3. 3
    Sarcopenia was associated with PSQI score (OR 1.10, 1.02-1.19). For sleep latency (1.14, 0.99-1.31) and later mid-sleep time (1.54, 0.91-2.61) the confidence intervals included 1, so those links were not statistically clear.
  4. 4
    Associations were somewhat stronger in women and varied by menopausal status.

Limites et incertitude

  1. 1
    Sleep and bone or muscle status were measured at the same time, so reverse causation is possible, and the title's label of 'risk factors' goes beyond cross-sectional data.
  2. 2
    The PSQI is a self-reported questionnaire, not objective sleep monitoring.
  3. 3
    Participants had a higher average BMI than a typical population sample (median 26, up to 56), and the abstract does not report how many had osteopenia or sarcopenia.
  4. 4
    Subgroup differences by sex and menopause are described only loosely in the abstract.

Mise en perspective

Worse sleep quality and later timing go along with lower bone and muscle mass in midlife, but this does not prove that improving sleep will protect bones or muscles. It is one more reason to treat regular, good-quality sleep as part of overall health. Concerns about bone density belong with your clinician.

Vos données

Wearables can record sleep timing, midpoint and latency, which map loosely onto the PSQI items. They estimate sleep less accurately than a lab, so compare your own weeks with each other on the same device and watch for consistent shifts rather than single nights.

Comprendre ce type de preuve

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Context

Sleep deprivation has detrimental metabolic consequences. Osteopenia and sarcopenia usually occur together and increase risk of fractures and disease. Results from studies linking sleep parameters to osteopenia or sarcopenia are scarce and inconsistent.

Objective

To examine the associations of sleep parameters with osteopenia and sarcopenia, considering the influence of sex and menopause.

Design, setting and participants

Cross-sectional analysis of 915 participants (45-65 years, 56% women, BMI 26 (range: 18-56) kg/m2) in the Netherlands Epidemiology of Obesity (NEO) study, a population-based cohort study. Sleep duration, quality, and timing were assessed with the Pittsburgh Sleep Quality Index (PSQI); bone mineral density and relative appendicular muscle mass were measured by DXA scans. Linear and logistic regressions were performed to associate sleep parameters to bone mineral density, relative appendicular muscle mass, osteopenia (t-score between -1 and -2.5) and sarcopenia (1 SD below average muscle mass).

Results

After adjustment for confounding factors, one unit increase in PSQI score (OR and 95% CI, 1.09, 1.03-1.14), declined self-rated sleep quality (1.76, 1.03-3.01), sleep latency (1.18, 1.06-1.31), and a one hour later sleep timing (1.51, 1.08-2.11), but not sleep duration (1.05, 0.90-1.23), were associated with osteopenia. PSQI score (1.10, 1.02-1.19) was also associated with sarcopenia; OR's of sleep latency and later mid-sleep time with sarcopenia were 1.14 (0.99-1.31) and 1.54 (0.91-2.61), respectively. Associations were somewhat stronger in women and varied per menopausal status.

Conclusions

These results suggest that decreased sleep quality and a later sleep timing are risk factors for osteopenia and sarcopenia in middle aged individuals.

Sources et attribution

Poor sleep quality and later sleep timing are risk factors for osteopenia and sarcopenia in middle-aged men and women: The NEO study.

Lucassen EA, de Mutsert R, le Cessie S, Appelman-Dijkstra NM, Rosendaal FR, van Heemst D, den Heijer M, Biermasz NR, NEO study group.

PloS one · 2017-05-01

DOI: 10.1371/journal.pone.0176685 ↗PubMed · 28459884 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Méta-analyse d’essais

Exercise improved sleep-quality scores in adults 45 and older with sleep disorders

Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.

Journal of Exercise Science & Fitness

Explications approfondiesLire l’étude →
·Étude de cohorte

Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults

Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.

Sleep

Explications approfondiesLire l’étude →
·Essai randomisé

Sleep extension cut daily energy intake by about 270 kcal in adults with overweight

In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.

JAMA Internal Medicine

Explications approfondiesLire l’étude →
·Étude de cohorte

Six hours or less of sleep at 50 and 60 linked to higher dementia risk

In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.

Nature Communications

Explications approfondiesLire l’étude →
Sommeil et rythmes →